Incidence and prognostic significance of nephrotoxicity in patients receiving eshap as salvage therapy for lymphoma

Autor:	Montse Batlle, Christelle Ferra, Marc Sorigue, Miriam Moreno, Gladys Ibarra, Alberto Pineda, Gustavo Tapia, Susanna Vives, Evarist Feliu, Juan-Manuel Sancho, Josep-Maria Ribera, David Lopez, Olga García
Rok vydání:	2017
Předmět:	Male Cancer Research ESHAP Lymphoma Survival medicine.medical_treatment Salvage therapy Kaplan-Meier Estimate Autologous stem cell transplantation Gastroenterology 0302 clinical medicine Antineoplastic Combined Chemotherapy Protocols Outpatients Medicine Prospective cohort study Nephrotoxicity Etoposide Incidence Incidence (epidemiology) Cytarabine Hematology Middle Aged Prognosis Oncology 030220 oncology & carcinogenesis Female Kidney Diseases medicine.drug Adult medicine.medical_specialty Renal function Methylprednisolone Young Adult 03 medical and health sciences Internal medicine Humans Aged Proportional Hazards Models Retrospective Studies Platinum Salvage Therapy Chemotherapy business.industry Surgery Cisplatin business 030215 immunology
Zdroj:	Leukemia Research r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol instname
ISSN:	0145-2126
Popis:	Nephrotoxicity is a well-known side effect of platinum-based chemotherapy. We retrospectively assessed the incidence and prognostic impact of nephrotoxicity with ESHAP rescue chemotherapy in 74 lymphoma patients (61 aggressive lymphomas). A higher incidence of nephrotoxicity (estimated glomerular filtration rate
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2b6e988ccd85fcdc8b0fae9ad76e17c https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6242 Zobrazit plný text záznamu Full Text from ScienceDirect